Table 2

Main multivariate analyses: effect of HLA mismatch on transplantation outcomes

Outcome (8/8 baseline, N=5447)7/8 (N = 2071) RR (95% CI)P value6/8 (N = 483) RR (95% CI)P value7/8 vs 6/8 RR (95% CI)
Acute GVHD II to IV 1.2 (1.1-1.4) <.0001 1.4 (1.2-1.5) .0001 NS 
Acute GVHD III to IV 1.6 (1.4-1.8) <.0001 1.8 (1.5-2.2) <.0001 NS 
Chronic GVHD 1.2 (1.1-1.3) <.0001 1.2 (1.0-1.4) NS NS 
Relapse  NS  NS  
TRM 1.5 (1.3-1.6) <.0001 1.8 (1.6-2.1) <.0001 0.8 (0.7-0.93), 0.003 
Treatment failure - early 1.3 (1.1-1.4) <.0001 1.9 (1.6-2.3) <.0001 0.7 (0.5-0.8), <0.0001 
Treatment failure – intermediate 1.3 (1.2-1.5) <.0001 1.5 (1.2-1.8) <.0001 NS 
Treatment failure – advanced 1.2 (1.0-1.3) .01 1.1 (0.9-1.3) NS NS 
Overall mortality – early 1.3 (1.1-1.4) <.0001 2.0 (1.7-2.5) <.0001 0.62 (0.5-0.8), <0.0001 
Overall mortality – intermediate 1.4 (1.2-1.6) <.0001 1.6 (1.3-2.0) <.0001 NS 
Overall mortality - advanced 1.2 (1.1-1.3) .002 1.1 (0.9-1.4) NS NS 
Outcome (8/8 baseline, N=5447)7/8 (N = 2071) RR (95% CI)P value6/8 (N = 483) RR (95% CI)P value7/8 vs 6/8 RR (95% CI)
Acute GVHD II to IV 1.2 (1.1-1.4) <.0001 1.4 (1.2-1.5) .0001 NS 
Acute GVHD III to IV 1.6 (1.4-1.8) <.0001 1.8 (1.5-2.2) <.0001 NS 
Chronic GVHD 1.2 (1.1-1.3) <.0001 1.2 (1.0-1.4) NS NS 
Relapse  NS  NS  
TRM 1.5 (1.3-1.6) <.0001 1.8 (1.6-2.1) <.0001 0.8 (0.7-0.93), 0.003 
Treatment failure - early 1.3 (1.1-1.4) <.0001 1.9 (1.6-2.3) <.0001 0.7 (0.5-0.8), <0.0001 
Treatment failure – intermediate 1.3 (1.2-1.5) <.0001 1.5 (1.2-1.8) <.0001 NS 
Treatment failure – advanced 1.2 (1.0-1.3) .01 1.1 (0.9-1.3) NS NS 
Overall mortality – early 1.3 (1.1-1.4) <.0001 2.0 (1.7-2.5) <.0001 0.62 (0.5-0.8), <0.0001 
Overall mortality – intermediate 1.4 (1.2-1.6) <.0001 1.6 (1.3-2.0) <.0001 NS 
Overall mortality - advanced 1.2 (1.1-1.3) .002 1.1 (0.9-1.4) NS NS 

NS, not significant.

Close Modal

or Create an Account

Close Modal
Close Modal